Areej M Jaber

6PUBLICATIONS
16CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsF-block chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2026
Hybrid amine-derived compounds as cytotoxic anticancer leads: design, synthesis, and biological evaluation.

|Oct 15, 2025
Thymoquinone chemically conjugated to doxorubicin: antitumor activity and subcellular localization.

Ismail Sami Mahmoud, Hamdi Nsairat, Shorouq Alsotari

|Jul 03, 2025
Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes.

Ali Al-Samydai, Hamdi Nsairat, Moath Alqaraleh

|Apr 22, 2025
Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity.

Mohammed M Al-Mahadeen, Areej M Jaber, Belal O Al-Najjar

|Dec 09, 2024
Discovery and Chemical Exploration of Spiro[Benzofuran-3,3'-Pyrroles] Derivatives as Innovative FLT3 Inhibitors for Targeting Acute Myeloid Leukemia.

Mohammed M Al-Mahadeen, Areej M Jaber, Jalal A Zahra

|May 31, 2024
Oleuropein impact on colorectal cancer.

Hamdi Nsairat, Areej M Jaber, Haya Faddah

Pageof 1

Frequent Collaborators

3 joint publications

Hamdi Nsairat

2 joint publications

Walhan Alshaer

2 joint publications

Belal O Al-Najjar

2 joint publications

Mohammed M Al-Mahadeen